Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment

Depression and Anxiety

Volumn 8, Issue 2, 1998, Pages 71-79

  Heuser, I ^a,d   Bissette, G ^b   Dettling, M ^a   Schweiger, U ^a   Gotthardt, U ^a   Schmider, J ^a   Lammers, C H ^a   Nemeroff, C B ^c   Holsboer, F ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Ctrl Institute of Mental Health J5   (Germany)

Author keywords

Amitriptyline; Corticotropin releasing hormone; Somatostatin; Vasopressin

Indexed keywords

AMITRIPTYLINE; CORTICOTROPIN RELEASING FACTOR; SOMATOSTATIN; VASOPRESSIN;

ADULT; AGED; AGING; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DEPRESSION; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; SOMATOSTATIN; VASOPRESSINS;

EID: 0031697426     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)8:2<71::AID-DA5>3.0.CO;2-N     Document Type: Article

References (81)

1. Holsboer F, Spengler D, Heuser I (1992) The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res 93:385-417.
2. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, McJames N, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 38 15-22.
3. Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerios P, Schulte H, Oldfield E, Loriaux DL (1984) Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 141:619-627.
4. Holsboer F, von Bardeleben U, Gerken A, Stalla GK, Muller OA (1984) Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor (h-CRF) in depression. N Engl J Med 311:1127.
5. Holsboer-Trachsler E, Stohler R, Hatzinger M (1991) Repeated administration of the combined dexamethasone/hCRH stimulation test during treatment of depression. Psychiatry Res 38:163-171.
6. Nemeroff CB, Widerlov E, Bissette G, Walléus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342-1344.
7. Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff MS, Nemeroff CB (1987) CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 144:7.
8. Arato M, Banki CM, Bissette G, Nemeroff CB (1989) Elevated CSF-CRF in suicide victims. Biol Psychiatry 25:355-359.
9. Roy A, Pickar D, Paul S, Doran A, Chrousos GP, Gold PW (1987) CSF corticotropin-releasing hormone in depressed patients and normal control subjects. Am J Psychiatry 144:641-645.
10. Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield Jr HJ, May C, Post RM, Chrousos GP, Gold PW (1991) Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. J Clin Endocrinol Metab 72:260-271.
11. Holsboer F, Liebl R, Hofschuster E (1982) Repeated dexamethasone suppression test during depressive illness. Normalization of test result compared with clinical improvement. J Affective Disord 4:93-101.
12. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z (1983) Dexamethasone suppression test in antidepressant treatment of melancholia - the process of normalization and test-retest reproductibility. Arch Gen Psychiatry 40:493-500.
13. Nemeroff CB, Bissette G, Akil H, Fink M (1991) Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotropin-releasing factor, -endorphin and somatostatin. Br J Psychiatry 158:59-63.
14. De Bellis MD, Gold PW, Geracioti Jr TD, Listwak SJ, Kling MA (1993) Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry 150:656-657.
15. Heuser IJE, Schweiger U, Gotthardt U, Schmider J, Lammers C-H, Dettling M, Holsboer F (1996) Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and in normal controls. Am J Psychiatry 153:93-99.
16. Gillies GE, Linton EA, Lowry PJ (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299:355-357.
17. von Bardeleben U, Holsboer F, Stalla GK, Müller OA (1985) Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci 37:1613-1618.
18. Whitnall MH, Mezey E, Gainer H (1985) Colocalization of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles. Nature 317:248-250.
19. Lightman SL, Young WS III (1988) Vasopressin, oxytocin, dynorphin, enkephalin and corticotropin-releasing factor mRNA stimulation in the rat. J Physiol (Camb) 403:511-523.
20. Gjerris A, Hammer M, Vendsborg P, Christensen NJ, Rafaelsen OJ (1985) Cerebrospinal fluid vasopressin: changes in depression. Br J Psychiatry 147:696-701.
21. Sørensen PS, Gjerris A, Hammer M (1985) Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. J Neurol Psychiatry 48:50-57.
22. McCann SM (1982) Physiology and pharmacology of LHRH and somatostatin. Ann Rev Pharmacol Toxicol 22:491-515.
23. Gerner RH, Yamada T (1982) Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res 238:298-302.
24. Rubinow DR (1986) Cerebrospinal fluid somatostatin and psychiatric illness. Biol Psychiatry 21:341-365.
25. Doran AR, Rubinow DR, Roy A, Pickar D (1986) CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients. Arch Gen Psychiatry 43:365-369.
26. Bissette G, Widerlov E, Walleus H, Karlsson I, Eklundt K, Forsman A, Nemeroff CB (1986) Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivity (SRIF-LI) in neuropsychiatrie disorders. Arch Gen Psychiatry 43:1148-1154.
27. Sunderland T, Rubinow DR, Tariot PN, Cohen RM, Newhouse PA, Mellow AM, Mueller EA, Murphy DL (1987) CSF somatostation in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects. Am J Psychiatry 144:1313-1316.
28. Molchan SE, Lawlor BA, Hill JL, Martinez RA, Davis CL, Mellow AM, Rubinow DR, Sunderland T (1991) CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression. Biol Psychiatry 29:1110-1118.
29. Charlton BG, Leake A, Wright C, Fairbairn AF, McKeith IG, Candy JM, Ferner IN (1988a) Somatostatin content and receptors in the cerebral cortex of depressed and control subjects. J Neurol Neurosurg Psychiatry 51:719-721.
30. Banki CM, Karmacsi L, Bissette G, Nemeroff CB (1992a) Cerebrospinal fluid neuropeptides in mood disorder and dementia. J Affective Disord 25:39-46.
31. Seeman TE, Robbins RJ (1994) Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 15:233-260.
32. Ferner IN, Pascual J, Charlton BG, Wright C, Leake A, Griffiths HW, Fairbairn AF, Edwardson JA (1988) Cortisol, ACTH, and dexamethasone concentrations in a psychogeriatric population. Biol Psychiatry 3:252-260.
33. Heuser IJ, Gotthardt U, Schweiger U, Schmider J, Lammers C-H, Dettling M, Holsboer F (1994) Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol Aging 15:227-231.
34. Gotthardt U, Schweiger U, Fahrenberg J, Lauer Ch, Holsboer F, Heuser I (1995) Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression. Am J Physiol 268:R865-R873.
35. Ravid R, Fliers F, Swaab DF, Zurcher C (1987) Changes in vasopressin and testosterone in the senescent Brown-Norway (BN/ BiRij) rat. Gerontology 53:87-98.
36. Goudsmit E, Hofman MA, Fliers E, Swaab DF (1990) The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease. Neurobiol Aging 11:529-536.
37. Lucassen PJ, Salehi A, Pool CW, Gonatas NK, Swaab DF (1994) Activation of vasopressin neurons in aging and Alzheimer's disease. J Neuroendocrinol 6:673-679.
38. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJG, Tilders FJH, Swaab DF (1995) Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 152:1372-1376.
39. Florio T, Ventra C, Postiglione A, Schettini G (1991) Age-related alterations of somatostatin gene expression in different rat brain areas. Brain Res 557:64-68.
40. Sonntag WE, Gottschall PE, Meites J (1986) Increased secretion of somatostatin-28 from hypothalamic neurons of aged rats in vitro. Brain Res 380:229-234.
41. Sato H, Ota Z, Ogawa N (1991) Somatostatin receptors in the senescent rat brain: a quantitative autoradiographic study. Regul Pept 33:81-92.
42. Spik K, Sonntag WE (1989) Increased pituitary response to somatostatin in aging male rats: relationship to somatostatin receptor number and affinity. Neuroendocrinology 50:489-494.
43. Raskind MA, Peskind ER, Lampe TH, Risse SC, Taborsky GJ, Dorsa D (1986) Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and -endorphin in Alzheimer's disease. Arch Gen Psychiatry 43:382-388.
44. Atack JR, Beal MF, May C, Kaye JA, Mazurek MF, Kay AD, Rapoport SI (1988) Cerebrospinal fluid somatostatin and neuropeptide Y concentration in aging and in dementia of the Alzheimer type with and without extrapyramidal signs. Arch Neurol 45:269-274.
45. Banki CM, Karmacsi L, Bissette G, Nemeroff CB (1992b) CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. Eur Neuropsychopharmacol 2:107-113.
46. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. rev., DSM-III-R. Washington, DC: American Psychiatric Association.
47. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
48. Post RM, Gold P, Rubinow DR, Ballenger JC, Bunney WE, Goodwin FK (1982) Peptides in cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function. Life Sci 31:1-15.
49. Owens MJ, Nemeroff CB (1988) The neurobiology of CRF: implications for affective disorders. In Schatzberg AF, Nemeroff CB (eds): The Hypothalamic-Pituitary-Adrenal Axis: Physiology, Pathophysiology, and Psychiatric Implications. New York: Raven Press, pp 1-36.
50. Plotsky PM, Owens MJ, Nemeroff CB (1995) Neuropeptide alterations in mood disorders. In Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 971-981.
51. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M (1988) Reduced corticotropin-releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45:577-579.
52. Charlton BG, Cheetham SC, Horton RW, Katona CLE, Crompton MR, Ferrier IN (1988b) Corticotropin-releasing factor immunoreactivity in post-mortem brains from depressed suicides. J Psychopharmacol 2:13-18.
53. Leake A, Perry EK, Perry RH, Fairbairn AF, Ferrier IN (1990) Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression. Biol Psychiatry 28:603-608.
54. Veith RC, Lewis N, Langohr JI, Murburg MAI, Ashleigh EA, Castillo S, Peskind ER, Pascualy M, Bissette G, Nemeroff CB, Raskind MA (1993) Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects. Psychiatry Res 46:1-8.
55. Pitts AF, Samuelson SD, Meller WH, Bissette G, Nemeroff CB, Kathol RG (1995) Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls. Biol Psychiatry 38:330-335.
56. Reul JMHM, Stec I, Söder M, Holsboer F (1993) Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamus-pituitary-adrenocortical system. Endocrinology 133:312-320.
57. Reul JMHM, Labeur MS, Grigoriadis DE, De Souza EB, Holsboer F (1994) Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 60:509-519.
58. Barden N, Reul JMHM, Holsboer F (1995) Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? TINS 28:6-11.
59. Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, Herkenham M (1991) Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in the rat brain. J Clin Invest 87.831-837.
60. Brady LS, Gold PW, Herkenham M, Lynn AB, Whitfield HJ Jr (1992) The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res 572:117-125.
61. Sapolsky RM (1991) Do glucocorticoid concentrations rise with age in the rat? Neurobiol Aging 13:171-174.
62. Van Eekelen JAM, Rots NY, Sutanto W, de Kloet, ER (1991) The effect of aging on stress responsiveness and central corticosteroid receptors in the Brown Norway rat. Neurobiol Aging 13:159-170.
63. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NPV, Meaney MJ (1994) Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14:2893-2903.
64. Cizza G, Calogero AE, Brady LS, Bagdy G, Bergamini E, Blackman MR, Chrousos GP, Gold PW (1994) Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age. Endocrinology 134:1611-1620.
65. Heroux JA, Grigoriadis DE, De Souza EB (1991) Age-related decreases in corticotropin-releasing factor (CRF) receptors in rat brain and anterior pituitary gland. Brain Res 542:155-158.
66. Hauger RL, Thrivikraman KV, Plotsky PM (1994) Age-related alterations of hypothalamic-pituitary-adrenal axis function in male Fischer 344 rats. Endocrinology 134:1528-1536.
67. Tizabi Y, Aguilera G, Gilad GM (1992) Age-related reduction in pituitary corticotropin-releasing hormone receptors in two rat strains. Neurobiol Aging 13:227-230.
68. Raadsheer FC, Hoogendijk WJG, Stam FC, Tilders FJH, Swaab DF (1994) Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60:436-444.
69. Levin N, Roberts IL (1991) Positive regulation of proopiomelanocortin gene expression in corticotropes and melanotropes. Front Neuroendocrinol 12:1-22.
70. Whitnall MH, Smyth D, Gainer H (1987) Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats. Neuroendocrinology 45:420-424.
71. De Goeij DCE, Kvetnansky R, Whitnall MH, Jezova D, Berkenbosch F, Tilders FJH (1991) Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology 53:150-159
72. Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry JM, Kiss JZ (1993) Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 132:895-902.
73. Purba JS, Hoogendijk WJG, Hofman MA, Swaab DF (1996) Increased number of vasopressin and oxytocin expressing neurons in the paraventricular nucleus of the human hypothalamus in depression. Arch Gen Psychiatry 53:137-143.
74. Raadsheer FC, Sluiter AA, Ravid R, Tilders FJH, Swaab DF (1993) Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res 615:50-62.
75. Rolandi E, Franceschini R, Messina V, Cataldi A, Salvemini M, Barreca T (1987) Somatostatin in the elderly: diurnal plasma profile and secretory response to meal stimulation. Gerontology 33:296-301.
76. Sonntag WE, Xu X, Ingram RL, D'Costa A (1995) Moderate caloric restriction alters the subcellular distribution of somatostatin mRNA and increases growth hormone pulse amplitude in aged animals. Neuroendocrinology 61:601-608.
77. Cuttler L, Welsh JB, Szabo M (1986) The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3 ,5 -monophosposphate-stimulated GH release from rat pituitary cells in monolayer culture. Endocrinology 119:152-158.
78. Kowalski C, Micheau J, Corder R, Gaillard R, Conte-Devolx B (1992) Age-related changes in corticoreleasing factor, somatostatin, neuropeptide Y, methionine enkephalin and -endorphin in specific rat brain areas. Brain Res 582:38-46.
79. Ferrara C, Cocchi D, Müller EE (1991) Somatostatin in the hippocampus mediates dexamethasone-induced suppression of corticosterone secretion in the rat. Neuroendocrinology 53:428-431.
80. Wolkowitz OM, Rubinow DR, Breier A, Doran AR, Davis C, Pickar D (1987) Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatrie illness. Life Sci 41:1929-1933.
81. Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP, Gold PW (1993) Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. Neuroendocrinology 57:79-88.